Product
treprostinil
Aliases
Remodulin
Name
Treprostinil
INN Name
treprostinil
FDA Approved
Yes
1 clinical trial
6 organizations
1 indication
4 documents
Indication
Pulmonary Arterial HypertensionClinical trial
Rapid Switch From Intravenous Epoprostenol to Intravenous Remodulin® (Treprostinil Sodium) Using the Crono Five Ambulatory Infusion Pump in Patients With Stable Pulmonary Arterial Hypertension (PAH): Safety, Efficacy and Treatment SatisfactionStatus: Terminated, Estimated PCD: 2009-09-01
Document
DailyMed Label: Tyvaso DPIDocument
DailyMed Label: TreprostinilOrganization
Par Pharmaceutical, Inc.Document
DailyMed Label: RemodulinOrganization
United Therapeutics CorporationOrganization
Alembic Pharmaceuticals Inc.Organization
Sandoz Inc. Document
DailyMed Label: TYVASOOrganization
Teva Parenteral Medicines, Inc.Organization
Dr.Reddy's Laboratories Inc.,